1460885762-f77ad3e8-57c7-4739-9598-72aeb9d61a6d

1-21. (canceled)
22. A method for treating neuroinflammation in a mammalian subject, comprising administering simultaneously, separately or sequentially to said subject, in need thereof, an effective amount of a combination of (i) an inhibitor of platelet aggregation selected from clopidogrel, cilostazol, ticlopidine, or tirofiban and (ii) a compound selected from mecamylamine, irbesartan, idraparinux, otamixaban, or SR48692, or salts or prodrugs or derivatives or sustained release formulations thereof.
23. The method of claim 22, wherein said combination comprises at least one of the following combinations of compounds:
Mecamylamine and Clopidogrel,
Otamixaban and Clopidogrel,
SR4896 and Clopidogrel,
Idraparinux and Clopidogrel,
Cilostazol and Idraparinux,
Cilostazol and Irbesartan,
Cilostazol and Mecamylamine,
Cilostazol and SR4896,
Mecamylamine and Clopidogrel and Otamixaban,
Mecamylamine and Clopidogrel and Irbesartan,
Mecamylamine and Clopidogrel and Idraparinux,
Mecamylamine and Clopidogrel and SR48692,
Mecamylamine and Cilostazol and Irbesartan,
Mecamylamine and Cilostazol and Irbesartan,
Mecamylamine and Cilostazol and Otamixaban, or
Mecamylamine and Cilostazol and SR48692.
24. The method of claim 22, wherein said neuroinflammation is caused by a neurodegenerative, autoimmune, infectious, toxic or traumatic disorder.
25. The method of claim 22, wherein said neuroinflammation is caused by multiple sclerosis (MS).
26. The method of claim 22, wherein said compounds are formulated in solid or liquid dosage forms, with one or several pharmaceutically acceptable excipients, for single or repeated administration to the subject.
27. The method of claim 22, comprising the following steps:
assessing whether a subject has neuroinflammation; and
treating the subject having neuroinflammation with an effective amount of a composition according to claim 22.
28. The method of claim 22, wherein said combination of at least two compounds is administered by oral, parenteral, intrathecal, topical, percutaneous or mucosal route or by inhalation.
29. The method of claim 22, wherein the inhibitor of platelet aggregation is clopidogrel, or a salt, prodrug, derivative, or sustained release formulation thereof.
30. The method of claim 22, which comprises administering to the subject an effective amount of a combination of Mecamylamine and Clopidogrel, or salts or prodrugs or derivatives or sustained release formulations thereof.
31. A method for treating multiple sclerosis in a mammalian subject, comprising administering simultaneously, separately or sequentially to said subject, in need thereof, an effective amount of a combination of (i) an inhibitor of platelet aggregation selected from clopidogrel, cilostazol, ticlopidine, or tirofiban, and (ii) a compound selected from mecamylamine, irbesartan, idraparinux, otamixaban, or SR48692, or salts or prodrugs or derivatives or sustained release formulations thereof.
32. The method of claim 31, which comprises administering to the subject a combination of mecamylamine and clopidogrel, or salts, prodrugs, derivatives or sustained release formulations thereof.
33. A composition comprising a combination of mecamylamine and clopidogrel, or salts, prodrugs, derivatives or sustained release formulations thereof, for simultaneous, separate or sequential administration.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. An ultrasonic probe comprising:
a base having a plurality of projections or recesses; and
a plurality of MUT elements arranged in each of the projections or recesses.
2. The ultrasonic probe according to claim 1, wherein the plurality of the projections are arrayed along a first direction, each of the projections being arranged in parallel to a second direction perpendicular to the first direction, each of the projections being elevated in a third direction perpendicular to the first and second directions, each of the projections having the shape of ridge running along the second direction.
3. The ultrasonic probe according to claim 2, wherein a plurality of vibration elements are arranged in the plurality of projections respectively,
each of the vibration elements having:
a plurality of MUT arrays arranged in the projection along the first direction,
each of the MUT arrays having:
the plurality of MUT elements arrayed in the projection along the second direction.
4. The ultrasonic probe according to claim 3, wherein each of the projections has three planes,
one of the three planes being perpendicular to the third direction,
three or more MUT arrays being arranged in the three planes.
5. The ultrasonic probe according to claim 3, wherein each of the projections has one surface curved in the third direction,
three MUT arrays being arranged in the curved one surface.
6. The ultrasonic probe according to claim 1, wherein the plurality of projections are two-dimensionally discretely arrayed on the base along a first direction and a second direction substantially perpendicular to the first direction, each of the projections being elevated in a third direction perpendicular to the first and second directions.
7. The ultrasonic probe according to claim 6, wherein a plurality of vibration elements are arranged in the plurality of projections respectively, and
each of the vibration elements has the plurality of MUT elements arranged in the first and second directions.
8. The ultrasonic probe according to claim 7, wherein each of the projections has six or eight planes,
one of the six or eight planes being substantially perpendicular to the third direction,
the plurality of MUT elements being arranged in the six or eight planes.
9. The ultrasonic probe according to claim 7, wherein each of the plurality of projections has one plane and one curved surface,
the one plane being substantially perpendicular to the third direction,
the plurality of MUT elements being arranged in the one plane and the one curved surface.
10. The ultrasonic probe according to claim 7, wherein each of the projections has one semispherical surface,
the semispherical surface being elevated in the third direction,
the plurality of MUT elements being arranged in the semispherical surface.
11. An ultrasonic probe comprising:
a base having a plurality of projections or recesses arrayed along at least one direction; and
a plurality of vibration elements arranged in the plurality of projections or recesses respectively, each of the vibration elements having ultrasonic radiation surfaces curved along the surfaces of each of the projections or recesses.
12. The ultrasonic probe according to claim 11, wherein each of the vibration elements has a plurality of MUT elements, the plurality of MUT elements being arranged in each of the projections or recesses.
13. The ultrasonic probe according to claim 11, wherein each of the vibration elements constitutes one channel.
14. An ultrasonic diagnostic apparatus comprising:
an ultrasonic probe according to claim 1;
a signal processing unit which subjects an echo signal from the ultrasonic probe to image processing to generate image data; and
a display unit which displays the generated image data.